AspireAssist

FDA-approved, reversible endoscopic weight loss procedure for people with obesity. Tweets to third party content are not endorsed by Aspire Bariatrics, Inc.

[AspireAssist @AspireAssist]

Eric was tickled after losing 167 pounds with the #AspireAssist. Read all about his weight loss journey! https://t.co/1NLdrUr0Tp

[AspireAssist @AspireAssist]

#Obesity itself increases risk of diabetes and heart disease. https://t.co/0WdZyc6R1f

[AspireAssist @AspireAssist]

#Obesity rates rise in 6 states, exceed 35% in 7. https://t.co/6k73jTC0D4

[AspireAssist @AspireAssist]

Did you know that working out with a jump rope is a extremely effective workout? It's a great form of cardio and doesn't require a gym membership to do it! #WorkoutWednesday

[Neil Floch MD @NeilFlochMD]

#Exercise has not been proven to result in significant long term #weightloss

[MNT Fitness & Weight Loss @mnt_weightloss]

Obesity: Researchers identify 4 subtypes https://t.co/VVGgIdJ5PO @mnt_weightloss #obesity #subtypes

[The Obesity Society @ObesitySociety]

Watch Dr. George Bray talked about obesity and diabetes. #diabetesawarenessmonth

[AspireAssist @AspireAssist]

We hope that you’re surrounded with the love of your dear ones on this day. Happy Thanksgiving to you and yours! #HappyThanksgiving

[Neil Floch MD @NeilFlochMD]

As #ow2018 ends, we must continue to diligently educate both medical community and public alike as to the actual causes of #obesity and related disease ow2018

[AspireAssist @AspireAssist]

"It’s not just about losing weight, it teaches you how to control yourself. It teaches you how to love yourself, it helps motivate you." Amber lost 70 pounds with the #AspireAssist. Hear her story now! https://t.co/zEDf7fchj0 #TestimonialTuesday

[WCRF International @wcrfint]

There is strong evidence that sugar-sweetened drinks INCREASE the risk of weight gain, overweight & obesity, which in turn increase the risk of 12 cancers. Find out more in our 'Energy balance & body fatness' report: https://t.co/T1VtBw4MaS #CancerPrevention

[Violeta Popov, MD PhD @PopovVioleta]

The PATHWAY trial with 4 years follow up. More than 65% of @AspireAssist patients maintained at least 10 % #weightloss , with average total weight loss of about 18%. @MetabolicEndo presenting @asmbs @ObesitySociety session during #ObesityWeek2018

[AspireAssist @AspireAssist]

With over 60,000 miles of trails in the National Trail System across the 50 states, there is no lack of opportunity to take a hike. So get outside and get moving! #NationalTakeAHikeDay

[AspireAssist @AspireAssist]

Fat-clogged cells explain why #obesity can cause cancer. https://t.co/81FnKTFQ1n

[AspireAssist @AspireAssist]

Don't forget about today's presentation on the #AspireAssist w/ Christopher Thomspon @ 10:40am: ‘ASPIRATION THERAPY FOR THE TREATMENT OF OBESITY: 2-4 year results of the PATHWAY multicenter randomized controlled trial (A106)’. Hope to see you there! #OW2018

[AspireAssist @AspireAssist]

Still at #ObesityWeek2018? Don't forget to stop by and meet the #AspireAssist team at Booth #901!

[AspireAssist @AspireAssist]

Interested in hearing firsthand feedback from actual #AspireAssist patients? Join our private Facebook community. Hear honest insights, discover what you can expect, and learn how to achieve success with the AspireAssist! https://t.co/cGe5bEB5Pe

[AspireAssist @AspireAssist]

At #ObesityWeek2018? Come meet Eric and hear how he lost 175 pounds with the #AspireAssist! #OW2018

[AspireAssist @AspireAssist]

Are you attending #ObesityWeek2018? Visit Aspire Bariatrics in the Exhibit Hall (Booth #901)! Stop by to meet our team and learn more about the #AspireAssist. #OW2018

[AspireAssist @AspireAssist]

Are you attending #ObesityWeek2018? Don’t miss tomorrow's presentation on the #AspireAssist w/ Christopher Thomspon @ 10:40am: ‘ASPIRATION THERAPY FOR THE TREATMENT OF OBESITY: 2-4 year results of the PATHWAY multicenter randomized controlled trial (A106)’. Hope to see you there!